GALDERMA GROUP N (GALD.SW) Deep Dive Video

A premium-valued dermatology pure-play compounding growth through a blockbuster biologic (Nemluvio) and next-gen aesthetics (Relfydess/Sculptra), with tariffs, FDA timing, and consumer cyclicality as the key swing factors.